The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Duhay Francis | Director | Sell(S) | 140 | $11.52 | $2K |
| Dec 16, 2025 | Glickman Marc H. | SVP & Chief Medical Officer | Other(J) | 100K | — | $0 |
| Dec 16, 2025 | Alavi Hamed | Chief Technology Officer | Other(J) | 50K | — | $0 |
| Dec 16, 2025 | Berman Robert Andrew | Chief Executive Officer, Director | Other(J) | 200K | — | $0 |
| Dec 11, 2025 | Duhay Francis | Director | Sell(S) | 5K | $0.36 | $2K |
| Dec 11, 2025 | Shrivastava Sanjay | Director | Grant(A) | 136K | — | $0 |
| Dec 11, 2025 | Jenusaitis Matthew | Director | Grant(A) | 136K | — | $0 |
| Dec 11, 2025 | Gray Robert | Director | Grant(A) | 136K | — | $0 |
| Dec 11, 2025 | Duhay Francis | Director | Grant(A) | 136K | — | $0 |
| Sep 15, 2025 | Duhay Francis | Director | Sell(S) | 5K | $0.83 | $4K |
| May 19, 2025 | Bright Jennifer | Chief Financial Officer | Grant(A) | 350K | — | $0 |
| Dec 31, 2024 | Gray Robert | Director | Buy(P) | 4K | $2.94 | $10K |
| Dec 31, 2024 | Duhay Francis | Director | Buy(P) | 81K | $3.07 | $250K |
| Dec 24, 2024 | Shrivastava Sanjay | Director | Buy(P) | 5K | $2.90 | $16K |
| Dec 19, 2024 | Berman Robert Andrew | Chief Executive Officer, Director | Buy(P) | 12K | $2.55 | $31K |
| Dec 19, 2024 | Jenusaitis Matthew | Director | Buy(P) | 10K | $2.53 | $24K |
| Dec 18, 2024 | Duhay Francis | Director | Grant(A) | 20K | — | $0 |
| Dec 18, 2024 | Alavi Hamed | Chief Technology Officer | Grant(A) | 75K | — | $0 |
| Dec 18, 2024 | Glickman Marc H. | SVP & Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Dec 18, 2024 | Jenusaitis Matthew | Director | Grant(A) | 20K | — | $0 |
| Dec 18, 2024 | Berman Robert Andrew | Chief Executive Officer, Director | Grant(A) | 200K | — | $0 |
| Dec 18, 2024 | Gray Robert | Director | Grant(A) | 20K | — | $0 |
| Dec 18, 2024 | Shrivastava Sanjay | Director | Grant(A) | 20K | — | $0 |
| Mar 13, 2024 | Alavi Hamed | Chief Technology Officer | Sell(S) | 8K | $6.22 | $52K |
| Mar 13, 2024 | Alavi Hamed | Chief Technology Officer | Option exercise(M) | 8K | $3.59 | $30K |
| Mar 13, 2024 | Alavi Hamed | Chief Technology Officer | Option exercise(M) | 8K | — | $0 |
| Dec 5, 2023 | Alavi Hamed | Chief Technology Officer | Grant(A) | 100K | — | $0 |
| Dec 5, 2023 | Berman Robert Andrew | Chief Executive Officer, Director | Grant(A) | 300K | — | $0 |
| Dec 5, 2023 | Duhay Francis | Director | Grant(A) | 14K | — | $0 |
| Dec 5, 2023 | Glickman Marc H. | SVP & Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Dec 5, 2023 | Gray Robert | Director | Grant(A) | 14K | — | $0 |
| Dec 5, 2023 | Jenusaitis Matthew | Director | Grant(A) | 14K | — | $0 |
| Dec 5, 2023 | Shrivastava Sanjay | Director | Grant(A) | 14K | — | $0 |
| Dec 5, 2023 | Glynn Craig | Chief Financial Officer | Grant(A) | 75K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).